| Stage | SUNB | % of rev | ROP | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $3.1B | 100.00% | $2.1B | 100.00% | SUNB ×1.48 |
| Gross profit | $1.2B | 40.10% | $1.5B | 69.71% | ROP +29.6pp |
| Operating income | $691M | 22.18% | $585M | 27.73% | ROP +5.5pp |
| Pre-tax income | $591M | 18.97% | $1.3B | 62.02% | ROP +43.1pp |
| Net income | $438M | 14.06% | $1.2B | 55.41% | ROP +41.3pp |
| Stage | SUNB | ROP | Gap · A − B |
|---|---|---|---|
| Revenue | $3.1B100.00% | $2.1B100.00% | SUNB ×1.48 |
| Gross profit | 40.10%$1.2B | 69.71%$1.5B | ROP +29.6pp |
| Operating income | 22.18%$691M | 27.73%$585M | ROP +5.5pp |
| Pre-tax income | 18.97%$591M | 62.02%$1.3B | ROP +43.1pp |
| Net income |
| 14.06%$438M |
| 55.41%$1.2B |
| ROP +41.3pp |
No disclosed counterparties: ROP.
None